Noninvasive cancer diagnostics are rapidly becoming an essential part of precision medicine therapies. These cutting-edge assays are not only useful in the preliminary diagnosis of various cancerous ...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. After developing GloFish and selling the IP for $50 million ...

A simple, scratch-and-sniff test could play a key role in curbing the spread of COVID-19, at a fraction of the cost of high-tech tests that are difficult to scale and take longer to return results, ...

In winter, various respiratory infectious diseases such as influenza (flu), pneumonia, and COVID-19 are prevalent at the same ...

Scientists develop PCR test that can detect the presence of nine genes, helping distinguish whether the germlings are male or female, and whether they are haploid or diploid A simple PCR test could be ...